During development, the proximal and distal regions of respiratory tract undergo distinct processes that ultimately give rise to conducting airways and alveoli. To gain insights into the genetic pathways differentially activated in these regions when branching morphogenesis is initiating, we characterized their transcriptional profiles in murine rudiments isolated at embryonic (E) day 11.5. By using oligonucleotide microarrays, we identified 83 and 128 genes preferentially expressed in branching and non-branching regions, respectively. The majority of these genes (85%) had not been previously described in the lung, or in other organs. We report restricted expression patterns of 22 of these genes were by in situ hybridization. Among them in the lung potential components of the Wnt, TGF beta, FGF and retinoid pathways identified in other systems, and uncharacterized genes, such as translocases, small GTPases and splicing factors. In addition, we provide a more detailed analysis of the expression pattern and regulation of a representative gene from the distal (transforming growth factor, beta induced) and proximal (WW domain-containing protein 2) regions. Our data suggest that these genes may regulate focal developmental events specific of each of these regions during respiratory tract formation.
Introduction
Development of the respiratory tract involves formation of the tracheobronchial tree and the alveoli; for most species this process spans the embryonic (E) and postnatal periods of life. In mice, primary lung buds and the tracheal primordium emerge independently from the primitive foregut at E9.5. Secondary lung buds appear a day later, and by E11-11.5 they branch to give rise to multiple generations of airways. Concurrently, both epithelial and mesenchymal components of these airways undergo proximal -distal (P-D) differentiation. Proximal regions will form the conducting airways, while the distal regions of the branching tubules will generate the future alveoli (reviewed in Cardoso, 2001; Hogan, 1999) .
Tissue recombination experiments in embryonic mouse or rat models have shown that distal lung mesenchyme is able to induce budding and distal gene expression in the developing proximal epithelium (Ohtsuka et al., 2001; Shannon et al., 1998; Wessells, 1970) . Differences in the morphogenetic potential of proximal and distal regions of the respiratory tract are evident from the earliest developmental stages. These ultimately reflect differences in the repertoire of signaling molecules present in epithelial and mesenchymal cells along the developing respiratory tract.
There is evidence that during early branching morphogenesis a distal signaling network is established in the E11-12 mouse lung to maintain proper growth and proximaldistal differentiation. For example, distal epithelial buds require local signaling by mesenchymal fibroblast growth factor Fgf10 for proper induction, while epithelial sonic hedgehog (Shh) and bone morphogenetic protein-4 (Bmp4) act as negative regulators of this process (reviewed in Cardoso, 2001; Hogan, 1999) . By contrast, the proximal non-branching region (main bronchi and trachea) is considered to be morphogenetically less active, proliferating less and starting cellular differentiation earlier (Mollard and Dziadek, 1998) . Sites where the proximal mesenchyme will give rise to tracheal cartilage primordia can be identified already at E11.5 by local expression of retinoic acid receptor gamma (Rarc), a critical regulator of this process (Mollard et al., 2000b) . In addition to regionally expressed regulatory molecules, extracellular matrix (ECM), cell adhesion molecules and even structural molecules are also part of local networks that influence local cellular behavior. Identifying global patterns of gene expression in proximal and distal regions is critical to understand how these differences in cellular behavior and phenotypes arise.
Recently, genome-wide discovery tools in combination with large scale in situ hybridization screen have been used to identify genes expressed in a temporal and spatial-specific fashion in a variety of developmental processes (Butler et al., 2003; Stathopoulos et al., 2002; White et al., 1999) . Similar approaches have been used to examine expression profiles during lung development. One of these studies examined whole lungs at different developmental stages (Mariani et al., 2002) , while others have focused on genes expressed are an individual germ layer (Liu and Hogan, 2002) or reported a particular regionally expressed gene (Lin and Shannon, 2002) .
Here, we used oligonucleotide microarrays to characterize the transcriptional profile of proximal and distal regions of the mouse respiratory tract at E11.5, when branching morphogenesis is initiating. We compared two regions with largely different morphogenetic potentials to gain insights into the pathways that potentially distinguish proximal nonbranching from the distal branching region. We provide a complete list of the microarray data, which show little overlap with previously published data. We report the spatial distribution of 22 previously uncharacterized genes. We show that the proximal region is enriched for genes encoding components of the RA pathway, ECM molecules that favor morphogenetic stabilization, including various procollagen genes and SRY-box transcription factors. In the distal region we found potential components of the Wnt, TGF beta and FGF signaling and other pathways reported elsewhere, but not in the lung. Some of these genes, such as translocases and splicing factors, were highly specific for the distal mesenchyme. From this survey we selected a representative distal (transforming growth factor, beta induced) and a proximal (WW domain-containing protein 2) gene for further analysis because of their unique expression pattern, which suggested a role in regulating specific events locally.
Material and methods

Lung dissection, RNA isolation, labeling and microarray hybridization
Lungs and lower third of trachea were dissected from the E11.5 CD1 mouse embryos. Branching and non-branching regions of the lung were separated as illustrated in Fig. 1 . Both right and left lungs were included for the analysis of the branching region. Total RNA from these samples was isolated using RNeasy (Qiagen) and then subjected to labeling and hybridization using the Affymetrix kit according to the manufacturer's manual.
Microarray data analysis
Three arrays (Affymetrix, MG-U74v2 set) were used per each experimental condition. A single weighted mean expression level for each gene along with a detection P value (which indicates whether the transcript was reliably detected) was derived using Microarray Suite 5.0 software (Affymetrix, Santa Clara, CA). We scaled the data from each array (target intensity of 500) to normalize the results for inter-array comparisons. The list of genes on this array is available at http://www.affymetrix.com/analysis/download _ center.affx. All data from our microarray experiments have been deposited in NCBI's Gene Expression Omnibus; the accession numbers for the samples are: GSM23483, GSM23484, GSM23485, GSM23486, GSM23487, GSM23488.
Each array's scanned image was examined for significant artifacts and the bacterial genes spiked into the hybridization mix had a detection P value below 0.05 (called present). In addition, several quality control metrics were assessed on each array. Background signals were within the recommendation limit (less than 100). The scaling factors used to normalize the target value ranged from 0.71 to 1.38 (within 4-fold standard limit). The 3V/5V ratios of Gapdh and betaactin ranged from 0.86 to1.75 (lower than the four fold standard limit). Genes with detection P values greater than 0.05 (called absent) in all six samples were eliminated from our analysis (55% in our case). A Student's t test was performed to identify genes differentially expressed between regions. Genes were considered differentially expressed if their fold change (FC) was greater than 1.75 with P value (on Student's t test) lower than 0.05. This combined statistical and fold change threshold helped us to focus on those genes with most significant changes and excluded potential artificial differences that could arise from low level or undetectable level gene expression in all our samples. The GoMiner software (Fish Exact T test, http://discover.nci.nih.gov/ gominer/) (Zeeberg et al., 2003) was used for statistical measure of representation of gene categories enriched in either the branching or non-branching regions. The list for all genes on the chip (Affymetrix, MG-U74v2 set) was input as the query gene file and each of the preferential expression gene list as the query changed gene file. All the information for three different categories in GO (Biological Process, Molecular Function and Cellular Component) was downloaded as Excel files. Categories with P value lower than 0.01 were selected for analysis, while the redundant and some subcategories were removed.
Lung organ culture
For the lung organ cultures, E11 -12 lungs from CD1 mice, or in some experiments, from RARE lacZ transgenic mice (Rossant et al., 1991) were dissected and placed onto MF-Millipore membrane filters (Whatman), on the top of a metal mesh on tissue culture dish, and cultured in BGjb medium (Sigma 20 mg/100 ml of ascorbic acid, 1% of inactivated fetal calf serum and 50 units/Ag penicillin/streptomycin). For some experiments, TGFh1 (human recombinant, 10 -50 ng/ml, R&D system), retinoic acid (10 À6 or 10 À5 M, Sigma) or BMS493 (10 À6 M, Bristol-Myers-Squibb) were added to the medium at the beginning of the culture, as previously described (Malpel et al., 2000; Mollard et al., 2000a; Serra et al., 1994) . Lung explants were harvested at 24 and 48 h, fixed in 4% paraformaldehyde and processed for whole mount in situ hybridization.
In situ hybridization
All cDNA clones used for probe labeling were from NIA Mouse 15K cDNA Clone Set, distributed by the Microarray Core Facility in Tufts University School of Medicine. The accession numbers for the cDNA clones are:
The cDNA inserts with SP6 promoter region were amplified by PCR using M13 primers. The DNA templates for the following genes were generated by PCR with the primers that have either T7 or T3 promoters. The primer sequences are: Dusp9 forward primer: 5V-AATTAACCCTCACTAAAGG CCTGTGCTTGAGCT-CTGATT-3V, Dusp9 backward primer: 5V-TAATACGACT-CACTATAGG GAGTGAGAGGTGAAGCTTCT-3V; Timm8a forward primer: 5V-AATTAACCCTCACT-AAAGGG CTATGGAGTGTTCCTGCAAT-3V, Timm8a backward primer: 5V-TAATACGACTCACTATAGGG ATG-GAATCGATGTCTACCAT-3V; CaII forward primer: AAT-TAACCCTCACTAAAGGG CCATATGAAGGTAGGA-TAAT, CaII backward primer: TAATACGACTCACTATA-GGG ATTGTGTTGTGGTATGTTAT; Srp20 forward primer: AATTAACCCTCACTAAAGGG CAGAGC-TATTGTAACGTCT, Srp20 backward primer: TAATAC-GACTCACTATAGGG GACTTGATACCAAGCTCAC; Slc4a1 forward primer: AATTAACCCTCACTAAAGGG GAACTAGAACTTGTGAGAGA, Slc4a1 backward primer: TAATACGACTCACTATAGGG ACAGA-CACGTTTATTGGCAA. PCR products were purified and used as template for probe labeling. DIG-labeled RNA probes were generated using the appropriate RNA polymerase, as described on the manufacturer's manual (Ambion). The quality of labeled RNA probes was assessed by gel electrophoresis. Whole mount in situ hybridization of freshly isolated E9.5-13 lungs or lung cultures was performed in 96-well plates as previously described (Wertz and Herrmann, 2000) .
Western blotting
Protein extracts from trachea and proximal regions of cultured lung explants (control, all-trans-RA 10 À6 M; n = 4 for each condition) were loaded for gel electrophoresis, then transferred onto nitrocellulose membrane, blocked with 5% milk in TBST and incubated overnight with RARg antibody (rabbit polyclonal antibody, Bioreagents, 1:2000) in TBST with 5% of milk. Immuno-Star HRP Chemiluminescent kit (Bio-rad) was used for secondary antibody reaction and signal development according to manufacturer's protocol. The membrane was stripped after RARg detection and then re-probed with anti a-tubulin antibody (1:5000, Sigma) following the same protocol.
Results and discussion
This study was designed to characterize the differences in the transcriptional profile of the branching vs. non-branching regions of the E11.5 mouse respiratory tract. We focused on E11.5 because (1) this represents one of the earliest stages in which the respiratory and the digestive tract have been completely separated; (2) all lobes are clearly identified and branching morphogenesis has just initiated; and (3) while a P -D axis has been already defined, epithelial tubules have not undergone terminal differentiation and are still able to be re-specified, as shown by grafting studies (Ohtsuka et al., 2001; Wessells, 1970) .
Validation of the array data
From the 12,500 known or predicted genes present on the array (Murine U74A v2, Affymetrix) we found 83 genes enriched in the branching region, and 128 genes enriched in non-branching region (FC > 1.75, P < 0.05; Tables 1 and 2 ). The microarray data were validated by comparing the results with published gene expression patterns in E11 -12 lungs, and by performing whole mount in situ hybridization of the genes whose expression in the lung had not previously characterized.
The majority of the genes identified in our survey had not been formerly described in the embryonic lung. We found that only 15% of the transcripts (13 out of 83) enriched in the branching region were previously reported in the distal lung (Table 1 and references therein). These included the distal lung marker Surfactant protein C (Sp-C) (Wert et al., 1993) , the transcription factors Pcna (proliferating cell nuclear antigen), N-myc, Foxf1a, Hoxb5 and b6, GATA5, Etv4(Pea3) and Snail (slug) (Holland and Hogan, 1988; Lim et al., 2002; Liu and Hogan, 2002; Moens et al., 1992; Morrisey et al., 1997; Savagner et al., 1998) , the signaling molecules Patched (receptor of Shh), Semaphorin 3A, platelet-derived growth factor B and the extracellular glycoprotein thrombospondin 1 (Bellusci et al., 1997; Han et al., 1992; Kagoshima and Ito, 2001; Liu and Hogan, 2002) . For the transcripts enriched in the non-branching region, 13% (17 out of 128) had already been reported in proximal lung (Table 2 and references therein). These included the transcription factors Pod1 (zinc finger protein 21), Rarc, Wnt5a, and pleiotrophin and its receptor (protein tyrosine phosphatase, receptor type, D) (Li et al., 2002; Lohnes et al., 1993a; Mollard et al., 2000b; Quaggin et al., 1999; Vanderwinden et al., 1992) , the cell adhesion molecules thrombospondin 2 and Gla; and cytoskeleton molecules such as Calponin 1, Cardiac alpha actin (Iruela-Arispe et al., 1993; Luo et al., 1995; Tollet et al., 2001) .
By in situ hybridization we confirmed proximal expression of four out of the five uncharacterized genes from the non-branching region, and distal expression of 18 out of 19 uncharacterized genes from the branching region. The overall agreement of our array data with published expression patterns and in situ hybridization results suggested that this approach reliably detects regional differences in gene expression in the E11.5 lung.
Factors influencing the outcome of the array data
We asked whether the proportion of epithelial to mesenchymal cells was markedly different in proximal and distal regions to bias the interpretation of the array data. This did not seem to be the case, since epithelial cytokeratins (Endo A and Endo B) and mesenchymal vimentin genes were not differentially enriched in any of the regions (P = 0.69 for Endo A; P = 0.52 for Endo B; P = 0.26 for vimentin). Moreover, in situ hybridization analysis showed that mesenchymal and epithelial genes were well represented in the gene lists from both regions.
We used the GoMiner Bioinformatics tool to find the representation of GO biological process categories in the gene lists originated from our screen (Zeeberg et al., 2003) . We found that the category associated with cell cycle and cell proliferation was the sole category overrepresented in the branching region. This was consistent with the increased proliferation activity of the distal lung. Analysis of the gene list from the non-branching region revealed that the categories overrepresented were associated with catalytic and proteolytic activities, smooth muscle formation and muscle contraction, extracellular matrix deposition, cell motility, extracellular matrix and cell adhesion (all at P < 0.01). These reflect the specific developmental events that occur in the more morphogenetically stable proximal regions. The low number of categories overrepresented in the distal region was somewhat surprising, since progenitor cells in the distal lung are expected to be more diverse and, thus, activate multiple genetic pathways. Presumably these genes could not be consistently detected by the microarray because their expression levels were too low or because they may have been restricted to a small population of cells. For example, Fgf10 transcripts were not detectable in our array. Bmp4, which is dynamically expressed in distal epithelium and in proximal and distal mesenchyme, was found enriched in proximal samples (Weaver et al., 2003) .
Identification of genes differentially expressed in the branching region
In situ hybridization analysis of the 18 previously uncharacterized genes enriched in the branching region revealed three major patterns of transcript distribution. Fig. 2 . Expression pattern of genes enriched in branching region (arrowheads) of E11.5 mouse lung by whole mount in situ hybridization (ISH). Group I consisted of genes expressed in the distal mesenchyme: (A) translocase of outer mitochondrial membrane 40 homolog (Tomm40); (B) translocase of inner mitochondrial membrane 8 homolog a (Timm8a); (C) splicing factor proline/glutamine rich (Sfpq); (D) splicing factor, arginine/serine-rich 3 (Srp20 or Sfrs3); (E) ectodermal-neural cortex 1 (Enc1); (F) proliferation-associated 2G4, 38 kDa (Pa2g4); (G) dual specificity phosphatase 9 (Dusp9); (H) Rab7, member RAS oncogene family (Rab7). Group II represents the genes expressed in both distal mesenchyme and epithelium: (I) mucin and cadherin like (Mucdhl); (J) EST (C79329); (K) EST (AK046712); (L) dedicator of cytokinesis 7 (Dock7). Group III are distal epithelial-specific genes: (M) zinc finger, DHHC domain containing 6 (Zdhhc6); (N) EST (AK48222); (O) reduced expression 3 (Rex3). Group IV includes genes expressed in blood cells: (P) solute carrier family 4 (anion exchanger), member 1 (Slc4a1, see also high magnification on the right); (Q) carbonic anhydrase 2 (CaII). Scale bar in A represents 250 AM.
Group I consisted of genes expressed solely in the distal mesenchyme. There were eight genes in this group: two translocases (Tomm40 and Timm8a), two splicing factors (Sfpq and Sfrs3), Enc1, Pa2g4, Dusp9 and Rab7.
Tomm40 (translocase of outer mitochondrial membrane 40 homolog) (Suzuki et al., 2000) and Timm8a (translocase of inner mitochondrial membrane 8 homolog) are mouse gene homologous of two yeast translocases( Figs. 2A and  B) . Timm8a is mutated in Deafness Dystonia Syndrome (MTS/DFN-1); its interaction with Signal Transduction Adaptor Molecule-1 (STAM1) has been reported. STAM1 is involved in cytokine signaling activity by interacting with Janus kinase (Blackstone et al., 2003; Roesch et al., 2002) . The restricted expression of two members of this family in overlapping domains of the distal mesenchyme is intriguing and suggests a potential role in intracellular transport of proteins.
Sfpq (splicing factor proline/glutamine rich) is a nuclear protein with multiple functions, including RNA splicing, transcriptional regulation and tumorigenesis ( Fig. 2C ) (Shav-Tal and Zipori, 2002) . Sfsr3 (similar to Splicing factor, arginine/serine-rich 3, also known as Srp20) has multiple roles in regulating constitutive and alternative splicing in vivo (Fig. 2D) . Sfsr3 homozygous null mutant embryos fail to form blastocysts, indicating the essential role of this gene during the initial stages of mouse development (Jumaa et al., 1999) .
Enc1 (ectodermal-neural cortex 1) is an actin-binding protein with Kelch domain known to be up-regulated by p53 in colorectal cancers and by the beta-catenin/TCF pathways in HeLa cells (Fig. 2E) (Fujita et al., 2001; Polyak et al., 1997) . Over-expression of Enc1 in HCT116 colon carcinoma cells results in increased tumor growth rate (Fujita et al., 2001) . Based on its restricted expression in distal mesenchyme and induction by beta-catenin/TCF, Enc1 is likely a candidate target of Wnt genes. Various Wnt family members have been identified in the distal lung, including Wnt2, Wnt5a (also in the proximal region), Wnt11 and Wnt7b. Wnt7b is of particular interest because of the severe lung hypoplasia and vascular defects reported in knockout mice (Shu et al., 2002) . Wnt7b is expressed in distal epithelial tubules and signals in the mesenchyme via the beta-catenin/ TCF pathway to regulate mesenchymal cell proliferation and vascular differentiation (Shu et al., 2002; Tebar et al., 2001) .
p38-2G4 (proliferation-associated protein 2G4), the gene encoding the proliferation-associated nuclear protein 38 kDa, is also restricted to the mesenchyme around distal buds (Fig. 2F) . Little is known about its function. p38-2G4 has potential methionyl aminopeptidase activity. In HeLa cells, expression of this gene is associated with specific phases of the cycle (Radomski and Jost, 1995) . Its distribution in the E11.5 lung suggests a selective role in proliferating distal mesenchymal cells.
Dusp9 (dual-specificity MAPK phosphatase-9 or Mkp-4) has been shown to inactivate ERK1/2 (extracellular signalregulated kinase-1/2) by de-phosphorylation (Fig. 2G ) (Dickinson et al., 2002) . Strong Dusp9 mRNA expression was detected in the peripheral layers of the distal mesenchyme near newly formed buds with lower signals in the interbud region of mesenchyme. These gradients suggest a dynamic expression pattern and presumably a role in regulating activity of ERK-dependent signals, such as FGF, in the lung mesenchyme. Based on its localization Dusp9 is likely a modulator of the Fgf9-Fgfr2c pathway (Colvin et al., 2001) .
Rab7 (Fig. 2H, RAB7 , member RAS oncogene family) is a member of the Rab family of GTPases and vesicle transport proteins. In Drosophila embryos, rab7 is required for the establishment of the gradient of decapentaplegic (dpp) through a transcytosis process. Dpp, the Drosophila homolog of the mammalian BMP, is required for proper segmentation of Drosophila embryo (Entchev and GonzalezGaitan, 2002) . In the E11.5 lung Rab7 could play a similar a role by controlling gradients of Bmp4, which is expressed by distal epithelial and subepithelial mesenchymal cells (Weaver et al., 2003) .
Group II includes genes expressed in both distal mesenchyme and epithelium. There are two known genes (Mucdhl and Dock7) and two ESTs (AK046712, Fig. 2K and C79329 , Fig. 2J ) in this group. Mucdhl, the mucin and cadherin-like gene, has been reported in fetal kidneys with different spliced isoforms (Fig. 2I) (Goldberg et al., 2002) . Dock7 (dedicator of cytokinesis 7) encodes a DOCK180-related protein with guanine nucleotide exchange activity (Fig. 2L ). Dock180 is upstream of the small GTPase Rac and has been implicated in Rac-dependent phagocytosis and cell migration in C. elegans. Dock180 (Dock1) is also involved in cell migration and invasion in COS-7 cells (Grimsley et al., 2004) . Dock7 may have a similar role in controlling cell movements during distal lung morphogenesis.
Group III consisted of genes with expression restricted to the distal epithelium. Zdhhc6, Rex3 and an EST (AK48222) (Figs. 2M -O) are representative of this group. Zdhhc6 (zinc finger, DHHC domain containing 6) is a novel transcription factor with DHHC-type zinc finger domain. Rex3 (reduced expression 3) is also known as Bex1 (brain expressed X-linked 1) and shares homologous sequences with Bex2 and Bex3. Bex3, also known as nerve growth factor receptor associated protein1, plays a role in nerve growth factor-induced apoptosis (Mukai et al., 2003) . Rex3 is of particular interest because of its regulation by RA (Faria et al., 1998) , and will be discussed subsequently. Expression of these genes is likely to be dynamic as the architecture of distal epithelial structures rapidly changes during branching.
An additional group (group IV), which included CaII (carbonic anhydrase 2) and Slc4a1 (solute carrier family 4, member 1) (Figs. 2P and Q) , represented the genes expressed by blood cells. These genes were enriched in the branching region, likely due to blood cell trapping in the highly vascular distal lung.
Identification of genes differentially expressed in the non-branching region
We determined the spatial distribution of four transcripts enriched in the non-branching region. In situ hybridization revealed a broad, homogenous distribution of transcripts throughout the proximal lung and trachea for all genes (Nfix, Ptn and AV230893) but one (Wwp2).
Nfix (nuclear factor I/X) is a CAAT box binding transcription factor from the Nuclear Factor I (NFI) family (Fig.  3B) . Members of this family regulate a variety of other genes with very diverse functions. For example, Renin, a regulator of arterial blood pressure, is one of the Nfix targets (Pan et al., 2004) .
Wwp2 (WW domain-containing protein 2) encodes a Nedd4-like ubiquitin-protein ligase. Nedd4 expression has been reported in proliferating and prehypertrophic chondrocytes during skeletal development (Weston and Underhill, 2000) ; however, no information about Wwp2 is currently available. We found that Wwp2 transcripts were restricted to a specific region in the ventral -lateral mesenchyme of the trachea and the main bronchi ( Fig. 3D and 5) . The similarity of the Wwp2 pattern with that of Rarc in this region (Mollard et al., 2000b) suggested that Wwp2 could be involved in local regulation of RA signaling. We selected Wwp2 as a candidate gene for further studies (see below).
Tgfbi is a potential mediator of the TGFb1 effects in the branching region Our array analysis revealed Tgfbi (hig-h3, TGF beta induced), a gene that encodes a cell adhesion-extracellular matrix protein, significantly enriched in the branching region. By in situ hybridization we found Tgfbi expression restricted to the stalk region of distal buds (Fig. 4C) . This localization was consistent with a role in suppressing local budding. The absence of signals in morphogenetically more stable proximal regions suggested that Tgfbi mediated responses and occur only in areas that are actively branching (Fig. 4C) . Although expression of Tgfbi in the embryonic lung and other organs had been reported, no systematic analysis of its expression pattern in developing airways, and its relationship to local signaling was available.
To gain additional insights into the developmental expression and regulation of Tgfbi by TGFh1, we extended our analysis to lungs at early stages in vivo and to cultured lung explants. We found Tgfbi transcripts in the lung mesenchyme as early as E9.5 -10, when primary buds are forming. In primary lung buds, expression was excluded from the mesenchyme surrounding the tips (Fig. 4A) . Later at E10.5, Tgfbi transcripts were localized to regions flanking the nascent secondary buds (Fig. 4B) . This dynamic pattern in regions immediately proximal to newly formed buds continues through E11 -12, and was also observed in lung cultures (Figs. 4C, D -I) .
Previous studies have shown that in the E11 -12 lung Tgfb1 is transcribed in the subepithelial mesenchyme, throughout its anterior -posterior axis (Lebeche et al., 1999; Schmid et al., 1991) . However, TGFh1 protein is accumulated in epithelial -mesenchymal interfaces of the stalks and clefts (Heine et al., 1990) , sites where we found Tgfbi mRNA expression.
Culturing E11.5 lung explants with exogenous TGFh1 (10 -50 ng/ml) resulted in distal expansion of the Tgfbi mRNA expression domain within 24 h (Fig. 4D right and  F) . By 48 h, TGFh1 treatment markedly inhibited lung growth and branching (Serra et al., 1994) , and resulted in diffuse up-regulation of Tgfbi in the distal mesenchyme (Figs.  4G -I ). The widespread distribution of Tgfbi transcripts in TGFh1-treated explants suggested that in the normal lung, endogenous gradients of TGFh1 restrict Tgfbi transcription to the stalk region of distal buds during branching. Whether this represents a direct or an indirect effect in gene transcription we could not determine based in our results. Culturing E11.5 lung with cyclohexamide, to inhibit protein synthesis, markedly affected the viability of the explants and reproducibility of the results (data not shown).
Tgfbi has been shown to mediate some of the TGFh1-related effects in biological processes. These include tumor suppression, apoptosis and promotion of cell adhesion (Kim et al., 2003; Zhao et al., 2002a Zhao et al., ,b, 2003 . Studies in cell lines suggest that, depending on the cell type, TGFh1 may either induce or prevent apoptosis (Horowitz et al., 2004 ). For example, in lung fetal mesenchymal cells IMR90, which express high levels of Tgfbi, TGFh1 signaling prevents cell death. Interestingly, during early branching, apoptosis is found predominantly in cleft mesenchymal cells (Levesque et al., 2000) . This suggests that activation of the Tgfb1-Tgfbi pathway may help to maintain a balance between apoptotic and non-apoptotic signals, perhaps favoring the latter. In epithelial cell lines, Tgfbi appears to function as a tumor suppressor gene, since its down-regulation has been associated with a tumorigenic phenotype (Zhao et al., 2002a (Zhao et al., ,b, 2003 . As a mediator of cell matrix interactions, Tgfbi has been shown to bind to various integrins to regulate cell adhesion, migration and proliferation (Bae et al., 2002) . Some of these integrins are present in the developing lung, where they can be critical for branching, as exemplified by a3h1 integrin (Kreidberg et al., 1996) . Taken together, these suggest that Tgfbi may be a local modulator of cell growth and presumably cell survival in specific regions of branching tubules.
Components of the RA pathway and RA targets were enriched in the proximal region Studies using a RARE lacZ reporter mouse have shown that branching morphogenesis is characterized by downregulation of retinoid signaling in distal but not in proximal regions of respiratory tract (Malpel et al., 2000; Mollard et al., 2000a) . In our screen, we found several known components of the RA signaling pathway and RA responsive genes differentially enriched in the non-branching region, where RA is maintained active; for example Rarc, cellular RA binding protein I (Crabp1), stimulated by RA gene 6 (Stra6), myeloid-associated differentiation marker (Myadm) and retinal short chain dehydrogenase reductase 1 (Tables 1  and 2 ; Bouillet et al., 1997; Cui et al., 2001; Rattner et al., 2000) .
Retinoid-related genes were underrepresented in the branching region. The only RA targets enriched in this region were either those, such as Hoxb5 and Hoxb6, 5V genes with low responsiveness to RA, which likely do not require RA to maintain their expression in the lung (Tables 1  and 2 ), or genes, such as Rex3, whose expression is downregulated by RA signaling. Rex3 was first described in F9 murine teratocarcinoma cells as a gene whose transcription is inhibited by retinoic acid (Faria et al., 1998) . In the E11.5 lung, the presence of Rex3 in the distal epithelium likely resulted from the local loss of RA activity. This could be part of a mechanism that allows further development of distal buds.
An ubiquitin ligase potentially associated with Rarc is differentially expressed in the non-branching region of the respiratory tract
In eukaryotes, activation of ubiquitin/proteasome-mediated proteolysis allows controlled degradation of regulatory molecules, including RARs. Ubiquitination is carried out by at least three classes of enzymes: ubiquitin-activating (E1), -conjugating (E2) and -protein ligases (E3) enzymes (Ciechanover et al., 2000) . One of the most interesting findings of our screen was the restricted expression of Wwp2, a gene encoding a Nedd4-like ubiquitin ligase in proximal regions of the E11.5 respiratory tract. The ventral and ventral -lateral pattern of transcript distribution in tracheal and proximal lung mesenchyme was highly similar to that described for Rarc. This became clearer when we analyzed lungs from E9.5 to E13.5 embryos (Figs. 5A -C) and when we found Wwp2 transcripts in extra pulmonary Rarc-expressing sites, such as the vertebral column (Fig. 5D) .
Studies in keratinocytes, COS 1 and F9 cells indicate that ubiquitin-mediated proteolysis regulates endogenous levels of RARg (Kopf et al., 2000) . Moreover, there is evidence that, at least in some of these cells, RA induces expression of enzymes of the ubiquitin pathway for RARg degradation (Kitareewan et al., 2002) . This prompted us to investigate the RA regulation of Wwp2 transcription and its relationship to Rar g expression in our system. We cultured E11.5 lungs from a RARE lacZ reporter mouse up to 72 h with RA (10 À6 to 10 À5 M) or BMS 493 (10 À6 M)-containing media to enhance or inhibit retinoid signaling, respectively (Mollard et al., 2000a; Malpel et al., 2000) . Efficacy of treatment was confirmed by monitoring lacZ expression in these cultures (Malpel et al., 2000; Rossant et al., 1991, data not shown) . Unexpectedly, we found that endogenous RA is not required for Wwp2 transcription in proximal airways, since antagonizing RA signaling did not affect Wwp2 expression (Figs.  6A -C) . In turn, exogenous RA significantly reduced Wwp2 transcription in a concentration-dependent manner in proximal airways (Figs. 6D, E) . To determine whether these treatments had an impact in RARg protein or transcripts levels, we performed in situ hybridization and Western blot analysis of tracheal and main bronchi regions isolated from these cultures. Figs. 6F-H confirmed data from previous studies in cell lines, which showed that RA does not induce Rarc transcription (Boudjelal et al., 2002; Yamamoto et al., 2000) . We found, however, that levels of RARg protein were increased in RA treated cultures, as compared to controls (Fig. 6I) . The most likely explanation is that RARg protein became more stable with the down-regulation of Wwp2 expression. This suggests that, under physiological conditions, Wwp2-mediated proteolysis contributes to regulate endogenous levels of RARg protein in the proximal mesenchyme.
The biological relevance of this observation resides in the fact that the sites where we found Wwp2 expression corresponded to the regions where Rarc is critical for the development of cartilage primodium in the respiratory tract and vertebrae (Figs. 5D and I) . Cartilage progenitor cells require tightly controlled RARg signaling for proper development. Deletion of the Rarc gene in mice results in defects in tracheal cartilage ring and anterior axial skeleton (Lohnes et al., 1993) . Moreover, there is in vivo and in vitro evidence that RARg is critical to mediate RA teratogenesis and to induce expression of the RA-metabolizing enzyme, Cyp26a1, when levels of RA increase to supra-physiological levels (AbuAbed et al., 1998) . We have previously shown that under similar conditions, RA treatment of E11.5 explants induces ectopic Cyp26a1 expression in the tracheal and proximal lung mesenchyme (Malpel et al., 2000) . Interestingly, these are essentially the same sites where we found Rarc and Wwp2 transcribed. We propose that down-regulation of Wwp2 mRNA and induction of Cyp26a1 gene expression by inappropriately high levels of RA may be part of a local mechanism that controls RA signaling and its effects in this region. Our model predicts that inhibition of Wwp2 expression by excess RA prevents normal RARg degradation. This ensures that there will be enough RARg available to mediate the RA teratogenic responses and to induce Cyp26a1, as an attempt to lower RA levels.
Concluding remarks
In summary, we provide the molecular signature of the branching and non-branching regions of the E11.5 mouse respiratory tract. The transcriptional profiles reported here provide insights into the global trends in gene expression associated with the developmental events that are typical of these regions. At E11.5 the distal lung is characterized by high branching activity, increased growth of both epithelial and mesenchymal compartments, and plasticity of distal progenitor cells. We found 83 genes enriched in the distal region. Many of these genes were associated with cell proliferation or had a potential link with local known regulatory pathways, such as the FGF or Wnt. Other genes, such as splicing factors and translocases, for which we had no previous information about their role in the distal lung, could represent, or be part of novel pathways to be investigated. Our profiling revealed 128 genes enriched in the proximal respiratory tract region. These included SRY transcription factors, BMPs, RA-related genes and a large number of extracellular matrix genes. Several of these genes have been associated with morphogenetic stability and formation of proximal mesenchymal derivatives, such as tracheal cartilage primordia and smooth muscle layers. In some cases we found representative members of the same gene family differentially expressed in each region. This was the case of thrombospondins 1 and 2, respectively, at distal and proximal sites.
The use of stringent criteria for gene selection and the complex cellular composition of the samples in our survey limited our ability to retrieve all important components of these networks. However, the validity and power of our approach in identifying potentially relevant genes for further functional analysis was well supported by our results. Consistent with this, we confirmed the majority of the selected genes at the expected location by in situ hybridization, and we could identify all major patterns of transcript distribution for both regions. Moreover, our screen was able to uncover genes, such as Tgfbi and Wwp2, localized to specific subpopulations of cells, where they are likely regulating specific developmental events. The database generated here also represents a valuable resource for comparisons with similar databases from embryonic kidney, salivary gland and other branching structures to identify common regulatory mechanisms.
